Diversion Control Division, US Department of Justice, Drug Enforcement Administration

RESOURCES > Federal Register Notices > Importers Notice of Registration - 2018 > Importer of Controlled Substances Registration

Importers Notice of Registration - 2018

[Federal Register Volume 83, Number 191 (Tuesday, October 2, 2018)]
[Pages 49579-49580]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-21354]


Drug Enforcement Administration

[Docket No. DEA-392]

Importer of Controlled Substances Registration

ACTION: Notice of registration.

SUMMARY: Registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as importers of various classes of schedule I or II controlled substances.

[[Page 49580]]

SUPPLEMENTARY INFORMATION: The companies listed below applied to be registered as importers of various basic classes of controlled substances. Information on previously published notices are listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for these notices.

Company FR Docket Published
AMRI Rensselaer, Inc 83 FR 15176 April 9, 2018
S&B Pharma, Inc 83 FR 31421 July 5, 2018
Cerilliant Corporation 83 FR 32906 July 16, 2018
Shertech Laboratories, LLC 83 FR 34879 July 23, 2018
Fresenius Kabi USA, LLC 83 FR 34878 July 23, 2018
VHG Labs DBA LGC Standards 83 FR 34875 July 23, 2018
Catalent Pharma Solutions, LLC 83 FR 34874 July 23, 2018
Fisher Clinical Services, Inc 83 FR 34879 July 23, 2018
Anderson Brecon, Inc 83 FR 37525 August 1, 2018

The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrants to import the applicable basic classes of schedule I or II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971.

The DEA investigated each company's maintenance of effective controls against diversion by inspecting and testing each company's physical security systems, verifying each company's compliance with state and local laws, and reviewing each company's background and history.

Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule I or II controlled substances to the above listed companies.

Dated: September 20, 2018.

John J. Martin,
Assistant Administrator.

[FR Doc. 2018-21354 Filed 10-1-18; 8:45 am]


NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Publishing Office (GPO).

Emergency Disaster Relief
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility